Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients

Table 1 Balance test for general information

		Cases (n)	Sex (male/female)	Age (mean ± SD)	Days of hospitalization (mean ± SD)
Fib (1.6-2.0 g/L) level	Research group	30	20/10	49.83 ± 12.32	35.73 ± 24.20
	Control group	30	21/9	44.67 ± 10.34	36.83 ± 18.15
	P value		0.781	0.084	0.843
Fib (1.1-1.5 g/L) level	Research group	30	20/10	50.27 ± 11.71	37.10 ± 19.94
	Control group	30	19/11	49.60 ± 10.45	30.37 ± 16.81
	P value		0.787	0.817	0.128
Fib ( ≤ 1.0 g/L) level	Research group	10	7/3	46.80 ± 8.92	41.70 ± 27.57
	Control group	15	10/5	43.20 ± 10.71	54.93 ± 37.10
	P value		1.000	0.389	0.346

Anyone in the three subgroups divided by the standard Fib level, age, sex and days of hospitalization was balanced between research and control groups before treatment.